Juha Luukkonen

Juha Luukkonen

Auto-generated profile, based on publicly available information

Juha Luukkonen

Helsinki Institute for Demography and Population Health, University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2023 in The Lancet Public Health
Verified
Journal Article
Open access
JLJuha Luukkonen
Juha Luukkonen
LTLasse Tarkiainen
Lasse Tarkiainen
PMPekka Martikainen
Pekka Martikainen
HRHanna Remes
Hanna Remes
Minimum legal drinking age (MLDA) is an effective policy tool in preventing youth drinking and short-term alcohol-attributable harm, but studies concerning long-term associations are scarce. In this register-based, national cohort study, we assessed alcohol-attributable morbidity and mortality of cohorts born in 1944-54 in Finland. Data were from the 1970 census, the Care Register for Healthcare (maintained by the Finnish Institute of Health and Welfare), and the Cause-of-Death Register (maintained by Statistics Finland). As MLDA was lowered from 21 years to 18 years in 1969, these cohorts were effectively allowed to buy alcohol from different ages (18-21 years). We used survival analysis to compare their alcohol-attributable mortality and hospitalisations with a 36-year follow-up. Compared with the first cohort (1951) allowed to buy alcohol from age 18, the hazard ratios (HRs) for alcohol-attributable morbidity and mortality were lower in cohorts who could not buy alcohol until age 20 or 21 years. For alcohol-attributable morbidity in those aged 21 years when the reform took place, HR was 0·89 (95% CI 0·86-0·93) for men and 0·87 (0·81-0·94) for women versus those aged 17 years. For alcohol-attributable mortality, HR was 0·86 (0·79-0·93) for men and 0·78 (0·66-0·92) for women aged 21 years when the reform took place. The outcomes of the later-born 1952-54 cohorts did not differ from the 1951 cohort. Earlier cohorts had consistently lower alcohol-attributable mortality and morbidity; however, other simultaneous increases in alcohol availability probably contributed to increased alcohol-related harm among the younger cohorts. Overall, differences between cohorts born only a few years apart highlight late adolescence as a crucial period for the establishment of lifelong patterns of alcohol use and suggest that higher MLDA could be protective for health beyond young adulthood. Yrjö Jahnsson Foundation, Foundation for Economic Education, Emil Aaltonen Foundation, Academy of Finland, European Research Council, and NordForsk.

6 February 2024 in European Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
JLJuha Luukkonen
Juha Luukkonen
HMHeta Moustgaard
Heta Moustgaard
PMPekka Martikainen
Pekka Martikainen
HRHanna Remes
Hanna Remes
The association between having older siblings and decreased risk for atopic symptoms is well-established. This has been interpreted as evidence for the microbiota hypothesis, i.e. that increased early-childhood microbial exposure caused by siblings protects from immune hypersensitivities. However, possible confounders of the association have received little attention. We used register data on Finnish cohorts born in 1995–2004 (N = 559,077) to assess medication purchases for atopic diseases: antihistamines, eczema medication, asthma medication and Epinephrine. We modelled the probability of atopic medication purchases at ages 0–15 by birth order controlling for important observed confounders and all unobserved genetic and environmental characteristics shared by siblings in a within-family fixed effects model. We further studied medication purchases among first-borns according to the age difference with younger siblings to assess whether having younger siblings in early childhood is beneficial. Having older siblings was associated with a lower probability of atopic medication purchases. Compared to first-borns, the probability was 10–20% lower among second-borns, 20–40% lower among third-borns, and 30–70% lower among subsequent children, depending on medication type. Confounding accounted for up to 75% of these differences, particularly for asthma and eczema medication, but significant differences by birth order remained across all medication types. Among first-borns, a smaller age difference with younger siblings was related to a lower likelihood of atopic medication use. Our results, based on designs that account for unobserved confounding, show that exposure to siblings in early childhood, protects from atopic diseases, and thus strongly support the microbiota hypothesis.


4 April 2025 in Epidemiology
Verified
Journal Article
Open access
JLJuha Luukkonen
Juha Luukkonen
EEElina Einiö
Elina Einiö
LTLasse Tarkiainen
Lasse Tarkiainen
PMPekka Martikainen
Pekka Martikainen
HRHanna Remes
Hanna Remes
Background: Little is known about how alcohol policies experienced in adolescence are associated with later health. We assess whether the age of exposure to stricter alcohol policies is associated with later alcohol-attributable hospitalizations and mortality. We take advantage of an alcohol advertising ban and alcohol tax increases introduced in 1975–1977 with relatively stable alcohol policies before and after. Methods: We used Finnish register data on birth cohorts 1950–1964 (1,175,878 individuals) to assess cohort-wise hazard ratios for the first incidence of alcohol-attributable hospitalization and mortality, and mortality due to external and other causes at ages 21–54 years. Results: Men who were aged 19–25 at the time of the restrictive reform had similar risks for alcohol-attributable hospitalization and mortality to the reference group of those aged 18—legal drinking age—at the time of reform. For those underage at the time, hospitalization and mortality rates were incrementally smaller cohort by cohort. For example, men who were 17 at the time of the reform had lower hazard ratios of alcohol-attributable hospitalization: 0.91 (95% confidence interval: 0.87, 0.95) as did those who were 13 (0.85; 95% confidence interval: 0.81, 0.89). The findings were similar for external-cause mortality, and similar yet more uncertain for women. In contrast, mortality from other causes declined continuously from cohort to cohort. Conclusions: Our findings are consistent with the hypothesis that stricter alcohol policies in adolescence reduce harmful alcohol consumption patterns extending into adulthood and manifesting as lower alcohol-related harm to health.

31 March 2026 in Journal of Epidemiology and Community Health
Verified
Journal Article
Open access
PDF file
JLJuha Luukkonen
Juha Luukkonen
JPJoonas Pitkänen
Joonas Pitkänen
LJLiina Junna
Liina Junna
LBLara Bister
Lara Bister
PMPekka Martikainen
Pekka Martikainen
HRHanna Remes
Hanna Remes
Background Parental death has well-established adverse effects on the mental health of children and adolescents, but evidence on adults is scarce. Also, the role of siblings has not been assessed before, even though siblings might be an important source of support during parental death. Methods We conducted a national cohort study to examine psychotropic medication purchases (antidepressants, anxiolytics, hypnotics and sedatives) before and after parental death and assessed differences by sibship size and sex of the offspring. We estimated annual probabilities of psychotropic medication purchases for 6 years surrounding parental death and compared men and women experiencing parental death from 2006 to 2016 at ages 35–55 years to a synthetic control group not experiencing parental deaths. Results We showed increased psychotropic medication purchases in the year before and after parental death. These associations were strongest for those with no or fewer siblings and among women. For example, after mother’s death, we observed an increase of 6.8 (95% CI 5.8 to 7.8) percentage points (pp) in psychotropic medication prevalence for women with no siblings in contrast to women whose mother did not die. For women with 1, 2 or 3 siblings, the respective differences were 6.1 (95% CI 5.5 to 6.8), 4.7 (95% CI 4.0 to 5.4) and 3.9 (95% CI 3.0 to 4.8) pp increases. The associations were also stronger after maternal than paternal death. Conclusions The findings may indicate that the burden of parental death is less substantial when several siblings are present. The more pronounced association among women may reflect gendered differences in treatment-seeking.

2 June 2025 in Pediatric Allergy and Immunology
Verified
Journal Article
Open access
JLJuha Luukkonen
Juha Luukkonen
HMHeta Moustgaard
Heta Moustgaard
HRHanna Remes
Hanna Remes
PMPekka Martikainen
Pekka Martikainen
Background: Previous evidence on season‐of‐birth differences in atopic diseases is partially mixed, and the etiology behind them is not well understood. For example, outdoor temperature may be an important modifier of the association but has been previously neglected. Methods: We assess how the month of birth is associated with medication use for atopic diseases at ages 0–15 and how outdoor temperatures after birth modify these associations for 0.55 million Finns born during 1995–2004. We used Finnish register data on purchases of medications used for allergic rhinitis, eczema, asthma, and food allergies. We predicted month‐of‐birth associations with medication use using extensive controls for observed and unobserved confounders and assessed effect modification by 3‐month mean outdoor temperature after birth. Results: Approximately half of the children had at least one purchase of medication used for atopic diseases. For children born in spring or summer, the probability of medication use was moderately lower than for children born in the autumn or winter. Among children born in the autumn or winter, exposure to the coldest outdoor temperatures in the first 3 months of life was associated with a nearly 10‐percentage‐point increase in the risk for medication use compared with the warmest temperatures. Conclusions: Behind the moderate overall associations between month of birth and childhood atopic diseases, there was notable variation by environmental conditions after birth, with cold weather after birth being particularly harmful. Future studies should assess what specific exposures do the outdoor temperatures affect, and in turn how they affect the development of atopic diseases.